Suppr超能文献

一项基于人群的研究,研究了不列颠哥伦比亚省儿童和青少年在 1996 年至 2011 年期间抗精神病药物处方趋势。

A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.

机构信息

University of Toronto, Toronto, Ontario, Canada.

出版信息

Can J Psychiatry. 2013 Jun;58(6):361-9. doi: 10.1177/070674371305800608.

Abstract

OBJECTIVES

To establish prevalence rates of antipsychotic (AP) prescriptions for children 18 years of age or younger in British Columbia (BC) from 1996 to 2011 by age, sex, AP type, and primary diagnosis; and to identify the predominant AP prescribers for children by specialty training.

METHODS

BC Ministry of Health administrative data were used to describe AP prescriptions for youth aged 18 years or younger. Comparisons were made using population prevalence based on sex; age group; AP; International Classification of Diseases, Ninth Revision, diagnosis; and prescriber specialty.

RESULTS

From 1996 to 2011, overall AP (both first and second generation) prescription prevalence rate increased 3.8-fold (1.66 to 6.37 per 1000 population); second-generation AP (SGA) prescriptions increased 18.1-fold (0.33 to 5.98 per 1000 population). The highest increase in all AP prescriptions occurred in males aged 13 to 18 years (3.3 to 14.4 per 1000 population; 4.4-fold), followed by similar increases in males aged 6 to 12 years (2.3 to 8.6 per 1000 population; 3.7-fold) and in females aged 13 to 18 years (2.8 to 10.7 per 1000 population; 3.8-fold). Overall, the 3 most common diagnoses associated with all AP prescriptions were depressive disorders (12.8%), hyperkinetic syndrome of childhood (11.7%), and neurotic disorders (11.1%); however, variation was observed by prescriber specialty training. Among all new AP prescriptions in 2010/11, 38.6%, 34.3%, and 15.6% were provided by psychiatrists, family physicians, and pediatricians, respectively.

CONCLUSIONS

There has been an exponential rise in SGA prescriptions in BC secondary to extensive off-label use, not only by psychiatrists but also by family physicians and pediatricians. Knowledge translation initiatives promoting evidence-based prescribing and monitoring practices related to SGA treatment need to target all 3 prescriber groups and be tailored for age subgroups.

摘要

目的

通过年龄、性别、抗精神病药物(AP)类型和主要诊断,确定不列颠哥伦比亚省(BC)18 岁及以下儿童 1996 年至 2011 年抗精神病药物的使用情况;并确定儿童抗精神病药物的主要处方医师。

方法

利用 BC 卫生部的行政数据,描述 18 岁以下儿童的抗精神病药物处方。根据性别、年龄组、AP、国际疾病分类、第九版、诊断和处方医师专业进行人群流行率比较。

结果

1996 年至 2011 年,所有 AP(第一代和第二代)处方流行率增加了 3.8 倍(每 1000 人中有 1.66 至 6.37 例);第二代抗精神病药物(SGA)处方增加了 18.1 倍(每 1000 人中有 0.33 至 5.98 例)。所有 AP 处方中,增幅最大的是 13 至 18 岁男性(每 1000 人中有 3.3 至 14.4 例;增加了 4.4 倍),其次是 6 至 12 岁男性(每 1000 人中有 2.3 至 8.6 例;增加了 3.7 倍)和 13 至 18 岁女性(每 1000 人中有 2.8 至 10.7 例;增加了 3.8 倍)。总体而言,与所有 AP 处方相关的 3 个最常见诊断是抑郁障碍(12.8%)、儿童多动综合征(11.7%)和神经症(11.1%);然而,按处方医师专业培训情况观察到了差异。在 2010/11 年所有新的 AP 处方中,分别有 38.6%、34.3%和 15.6%由精神科医生、家庭医生和儿科医生开具。

结论

由于广泛的非标签使用,尤其是精神科医生、家庭医生和儿科医生的非标签使用,BC 省 SGA 处方数量呈指数级增长。需要向所有 3 个处方医生群体推广促进基于证据的处方和监测实践的知识转化倡议,并根据年龄亚组进行调整。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验